Adult Intensive Care Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom.
Burns. 2013 Mar;39(2):200-11. doi: 10.1016/j.burns.2012.10.013. Epub 2012 Nov 24.
Optimal management of the acute respiratory distress syndrome (ARDS) requires prompt recognition, treatment of the underlying cause and the prevention of secondary injury. Ventilator-associated lung injury (VALI) is one of the several iatrogenic factors that can exacerbate lung injury and ARDS. Reduction of VALI by protective low tidal volume ventilation is one of the only interventions with a proven survival benefit in ARDS. There are, however, several factors inhibiting the widespread use of this technique in patients with established lung injury. Prevention of ARDS and VALI by detecting at-risk patients and implementing protective ventilation early is a feasible strategy. Detection of injurious ventilation itself is possible, and potential biological markers of VALI have been investigated. Finally, facilitation of protective ventilation, including techniques such as extracorporeal support, can mitigate VALI.
急性呼吸窘迫综合征(ARDS)的最佳治疗需要及时识别、治疗基础病因和预防继发损伤。呼吸机相关性肺损伤(VALI)是加重肺损伤和 ARDS 的医源性因素之一。保护性低潮气量通气可减少 VALI,这是唯一一种经证实可改善 ARDS 患者生存率的干预措施。然而,有几个因素抑制了该技术在已发生肺损伤患者中的广泛应用。通过早期检测高危患者并实施保护性通气来预防 ARDS 和 VALI 是一种可行的策略。损伤性通气本身是可以检测的,并且已经研究了 VALI 的潜在生物学标志物。最后,通过体外支持等技术来促进保护性通气,可以减轻 VALI。